Publications

August 2008 (Revised September 2008)
Case

The Flaxil Label (B)

This case focuses on the 2001 negotiation between Mytex Pharmaceuticals and the U.S. Food and Drug Administration (FDA). The outcome of the negotiation would determine the new label for Mytex's blockbuster drug for arthritis, Flaxil. The negotiation is quite... View Details

Keywords: Governance; Risk and Uncertainty; Value Creation; Negotiation; Attitudes; Health Care and Treatment; Government Administration; Pharmaceutical Industry; United States

13 Sep 2010
Research & Ideas

The Consumer Appeal of Underdog Branding

large corporations, such as Apple and Google, are careful to retain their underdog roots in their brand biographies." A forthcoming article coauthored by Keinan for the... View Details

Keywords: by Martha Lagace

27 Sep 2013
Working Paper Summaries

The Impact of Conformance and Experiential Quality on Healthcare Cost and Clinical Performance

Keywords: by Claire Senot, Aravind Chandrasekaran, Peter T. Ward & Anita L. Tucker; Health

19 Apr 2010
Research & Ideas

The History of Beauty

the consumer products giant Unilever, published some years ago. This company had a long-established business in soap and other toiletries, but spent decades after World War II striving without great success... View Details

Keywords: by Sean Silverthorne; Beauty & Cosmetics

26 Feb 2007
Research & Ideas

The Power of the Noncompete Clause

his noncompete and avoid similar entanglements. Q: How did you frame and carry out this study, and why in Michigan? A: Other studies had looked at rates of firm foundings, but we wanted to track the mobility... View Details

Keywords: by Martha Lagace

August 2008 (Revised September 2008)
Supplement

The Flaxil Label (C): Debrief and Endnotes

This case focuses on the 2001 negotiation between Mytex Pharmaceuticals and the U.S. Food and Drug Administration (FDA). The outcome of the negotiation would determine the new label for Mytex's blockbuster drug for arthritis, Flaxil. The negotiation is quite... View Details

Keywords: Safety; Value Creation; Negotiation; Health Care and Treatment; Sales; Pharmaceutical Industry

2009
Book

Who Killed Health Care? America's $2 Trillion Medical Problem—and the Consumer-Driven Cure

By: Regina Herzlinger

A best seller in its category, with many printings. It has been recognized by the U.S. Chamber of Commerce as one of the books that made a difference in public policy in 2008. View Details

Keywords: Policy; Government Administration; Health Care and Treatment; United States

Find at Harvard

05 Nov 2009
Research & Ideas

A Market for Human Cadavers in All but Name?

that its legality and limited occurrence underline crucial new developments in markets for anatomical goods. While the international organ trade is almost unanimously condemned, human cadavers can legally... View Details

Keywords: by Michel Anteby; Health

Article

Are Cost Advantages from a Modern Indian Hospital Transferable to the United States?

By: R. S. Kaplan, F. Erhun, V.G. Narayanan, B. Mistry and K. Brayton, et al

We use time-driven activity-based costing to estimate the cost of personnel and space for an elective coronary artery bypass graft (CABG) surgery at two U.S. hospitals, Intermountain and Baylor Heart, and Narayana Health (NH), in India. All three hospitals use modern... View Details

Keywords: Time-Driven Activity-Based Costing; Health Care and Treatment; Cost; Organizational Structure; Performance Efficiency; India; United States

Read Now

Article

Management Practices, Relational Contracts and the Decline of General Motors

By: Susan Helper and Rebecca Henderson

General Motors was once regarded as one of the best managed and most successful firms in the world, but between 1980 and 2009 its share of the U.S. market fell from 62.6% to 19.8%, and in 2009 the firm went bankrupt. In this paper we argue that the conventional... View Details

Keywords: Organizational Design; Management Practices and Processes; Insolvency and Bankruptcy; Manufacturing Industry; Auto Industry; United States

Find at Harvard

May 2024 (Revised February 2025)
Case

Choosing the Course of Passion: Brooke Boyarsky Pratt at knownwell

By: Jon M. Jachimowicz and Alexis Lefort

Brooke Boyarsky Pratt (HBS ’13) enjoyed considerable success in her early career, quickly climbing the ranks to associate partner at McKinsey, and later becoming an executive vice president at Berkadia, a Berkshire Hathaway portfolio company. Throughout these years,... View Details

Keywords: Passion; Career; Career Planning; Purpose; Personal Development and Career; Mission and Purpose; Identity; Business Startups; Health Care and Treatment; Health Disorders; Growth and Development Strategy; Market Entry and Exit; Health Industry; United States

08 Oct 2010
What Do You Think?

Will Transparency in CEO Compensation Have Unintended Consequences?

can report from experience that differences in philosophy concerning compensation, say between Europe and the U.S., pose real issues. Not only do European CEOs and board members regard View Details

Keywords: by Jim Heskett

10 Jun 2008
First Look

First Look: June 10, 2008

$1.6 billion. The case explores the reasons for the success of this global venture. Purchase this case: http://www.hbsp.harvard.edu/b01/en/common/item_detail.jhtml?id=808127... View Details

Keywords: Martha Lagace

21 Aug 2006
Research & Ideas

How Europe Wrote the Rules of Global Finance

Finance, forthcoming from Harvard University Press, Abdelal discusses the rise and diminishment of capital controls in the 1900s, the coming... View Details

Keywords: by Ann Cullen

03 Oct 2007
Research & Ideas

Dealing with the ‘Irrational’ Negotiator

to ensure that she understands why the offer is in her best interest. She may simply have misunderstood or ignored a crucial piece of information. Mistake 2: They Are Not Irrational; They Have Hidden... View Details

Keywords: by Deepak Malhotra & Max H. Bazerman

September 2011
Supplement

Expansion at Narayana Hrudayalaya

By: Tarun Khanna and Tanya Bijlani

Narayana Hrudayalaya has expanded into a multi-specialty health city in Bangalore, with a 25-acre campus that offers complex tertiary care procedures ranging from orthopedics to cancer care. In 2008, NH raised private equity from JP Morgan and Pinebridge Investments to... View Details

Keywords: Investment; Price; Health Care and Treatment; Emerging Markets; Social Enterprise; Expansion; Health Industry; Bangalore; Cayman Islands; Miami

August 2001 (Revised August 2012)
Case

BestDoctors, Inc.

By: Regina E. Herzlinger and Seth Bokser

Upon learning the news of a critical illness, patients and their families are shocked, saddened, fearful, and angry all at once. And just as soon as they catch their collective breath, they all ask the same question—a question that has the potential to infuse hope into... View Details

Keywords: Business Model; Entrepreneurship; Health Care and Treatment; Medical Specialties; Knowledge Sharing; Demand and Consumers; Health Industry

2013
Working Paper

The Impact of Conformance and Experiential Quality on Healthcare Cost and Clinical Performance

By: Claire Senot, Aravind Chandrasekaran, Peter T. Ward and Anita L. Tucker

The quality of operational processes is an important driver of performance in hospitals. In particular, processes that reliably deliver both evidence-based and patient-centered care, which we call conformance and experiential quality, respectively, have been argued to... View Details

Keywords: Healthcare; Experiential Quality; Conformance Quality; Clinical Outcomes; Cost Efficiency; Quality; Service Operations; Health Care and Treatment; Performance; Outcome or Result; Health Industry